Near East University established a Viral Vaccines Research and Production Center and started working to develop a COVID-19 vaccine. In the center, which will produce the TRNC’s domestic COVID-19 vaccine, vaccines will also be developed for many viral diseases.

Also available in: Türkçe

Added On: 02 September 2021, Thursday, 13:59
Last Edited On: 02 September 2021, Thursday, 16:31
Near East University established a Viral Vaccines Research and Production Center and started working to develop a COVID-19 vaccine. In the center, which will produce the TRNC’s domestic COVID-19 vaccine, vaccines will also be developed for many viral diseases.

Near East University started COVID-19 vaccine studies
Near East University established a “Viral Vaccines Research and Production Center” by taking an important step in developing and producing vaccines that are critical for many viral diseases, especially COVID-19. Near East University, which has started working to develop the TRNC’s domestic COVID-19 vaccine, will also develop vaccines for many viral diseases along with COVID-19.

Near East University established a Viral Vaccines Research and Production Center and started working to develop a COVID-19 vaccine. In the center, which will produce the TRNC’s domestic COVID-19 vaccine, vaccines will also be developed for many viral diseases.

Near East University also produced the TRNC’s native PCR Diagnosis and Variant Analysis kit to be used in the fight against the COVID-19 pandemic and started to use it with the approval of the TRNC Minister of Health. In addition, the COVID-19 preventive nasal spray developed in partnership with Perugia University, European Biotechnology Association (EBTNA) and Italian MAGI Group has recently been made available in the TRNC.

Near East University established a Viral Vaccines Research and Production Center and started working to develop a COVID-19 vaccine. In the center, which will produce the TRNC’s domestic COVID-19 vaccine, vaccines will also be developed for many viral diseases.
Prof. Dr. İrfan Suat Günsel: “After our domestic car GÜNSEL and our own PCR kit, we will also have our own COVID-19 vaccine, which we will develop and produce with national resources.”
Announcing that they started COVID-19 vaccine studies by establishing a Viral Vaccines Research and Production Center, Near East University Chairman of the Board of Trustees Prof. Dr. İrfan Suat Günsel said, “We are on the verge of a breakthrough with the courage given by the scientific infrastructure of Near East University and the capacity to produce science. As the Turkish Republic of Northern Cyprus, we will have our own COVID-19 vaccine, which we will develop and produce with national resources, after our domestic car GÜNSEL and our own PCR kit.

Stating that the COVID-19 vaccine to be developed will make a great contribution to the TRNC’s struggle to exist on the world stage, Prof. Dr. Günsel said, “The viral vaccines to be produced in our Viral Vaccines Research and Production Center will provide very important gains to our country in terms of academic and economic aspects.” Emphasizing that the basis of independence is the capacity to meet the needs of his own people, Prof. Dr. İrfan Sut Günsel said, “With this success, our Turkish Republic of Northern Cyprus will increase its prestige in the world, by making its name with Turkey among countries such as Germany, China, Russia, the USA and the UK, which have managed to produce a COVID-19 vaccine so far.”

Near East University established a Viral Vaccines Research and Production Center and started working to develop a COVID-19 vaccine. In the center, which will produce the TRNC’s domestic COVID-19 vaccine, vaccines will also be developed for many viral diseases.
Prof. Dr. Tamer Şanlıdağ: “With the Viral Vaccines Research and Production Center, we will carry out vaccine studies for many viral diseases, together with the COVID-19 vaccine.”
Near East University Acting Rector Prof. Dr. Tamer Şanlıdağ emphasized that with the Viral Vaccines Research and Production Center established, they will carry out important scientific projects by conducting vaccine studies related to many viral diseases, together with the COVID-19 vaccine. Emphasizing that an important gap have been filled up by developing and putting into public use the local PCR Diagnosis and Variant Analysis Kit and the COVID-19 preventive nasal spray, Prof. Dr. Şanlıdağ said, “We will undertake another unique project that will be made available to the public by developing and producing the indigenous vaccines of the TRNC, taking into account the science and public health potentials of our university.”